24 related articles for article (PubMed ID: 16798644)
1. Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
Kontoghiorghes GJ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902402
[TBL] [Abstract][Full Text] [Related]
2. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.
Kontoghiorghes GJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430469
[TBL] [Abstract][Full Text] [Related]
3. Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.
Kontoghiorghes GJ
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743183
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Radiat Prot Dosimetry; 2009 Jan; 133(1):12-9. PubMed ID: 19168864
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
[TBL] [Abstract][Full Text] [Related]
6. The effects of bicarbonate and its combination with chelating agents used for the removal of depleted uranium in rats.
Fukuda S; Ikeda M; Nakamura M; Katoh A; Yan X; Xie Y; Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):191-8. PubMed ID: 18274996
[TBL] [Abstract][Full Text] [Related]
7. Effects of pH on du intake and removal by CBMIDA and EHBP.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Health Phys; 2007 Jan; 92(1):10-4. PubMed ID: 17164594
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnostic indicators of renal and bone damage in rats intramuscularly injected with depleted uranium.
Fukuda S; Ikeda M; Chiba M; Kaneko K
Radiat Prot Dosimetry; 2006; 118(3):307-14. PubMed ID: 16436523
[TBL] [Abstract][Full Text] [Related]
9. Radiation protection by deferiprone in animal models.
Fukuda S; Ikeda M; Anzai K; Suzuki M; Katoh A; Kontoghiorghes GJ
Hemoglobin; 2006; 30(2):201-8. PubMed ID: 16798644
[TBL] [Abstract][Full Text] [Related]
10. Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Fukuda S
Curr Med Chem; 2005; 12(23):2765-70. PubMed ID: 16305471
[TBL] [Abstract][Full Text] [Related]
11. The toxicological mechanisms and detoxification of depleted uranium exposure.
Yue YC; Li MH; Wang HB; Zhang BL; He W
Environ Health Prev Med; 2018 May; 23(1):18. PubMed ID: 29769021
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
